Which practice most effectively prolongs the duration of a local anesthetic at the injection site while managing toxicity risk?

Which practice most effectively prolongs the duration of a local anesthetic at the injection site while managing toxicity risk?

• A. Using a vasoconstrictor with a minimal dose
• B. Using no vasoconstrictor
• C. Using a vasoconstrictor with an appropriately chosen concentration
• D. Using the highest possible concentration without a vasoconstrictor

Answer: (C)

Prolonging how long a local anesthetic stays active at the injection site hinges on keeping the drug near the nerve and reducing how quickly it is washed away by the blood. A vasoconstrictor accomplishes this by narrowing the local blood vessels, which slows systemic absorption and lets the anesthetic linger longer at the target site. The crucial part is using a concentration that achieves this effect effectively without pushing the dose into unsafe levels. Therefore, combining a vasoconstrictor with an appropriately chosen concentration provides the best balance of extended local action and controlled toxicity risk. Using a vasoconstrictor at a minimal dose may not produce enough vasoconstriction to significantly extend duration. No vasoconstrictor leads to faster uptake and shorter duration. The highest concentration without a vasoconstrictor raises toxicity and tissue risk without the safety and duration benefits that a proper vasoconstrictor concentration offers.

Prolonging how long a local anesthetic stays active at the injection site hinges on keeping the drug near the nerve and reducing how quickly it is washed away by the blood. A vasoconstrictor accomplishes this by narrowing the local blood vessels, which slows systemic absorption and lets the anesthetic linger longer at the target site. The crucial part is using a concentration that achieves this effect effectively without pushing the dose into unsafe levels. Therefore, combining a vasoconstrictor with an appropriately chosen concentration provides the best balance of extended local action and controlled toxicity risk. Using a vasoconstrictor at a minimal dose may not produce enough vasoconstriction to significantly extend duration. No vasoconstrictor leads to faster uptake and shorter duration. The highest concentration without a vasoconstrictor raises toxicity and tissue risk without the safety and duration benefits that a proper vasoconstrictor concentration offers.